Project Title |
Researchers |
Year |
Funding Agency |
Status |
Discovery of New HER2 Inhibitors via Ligand-Based Pharmacophore Modeling and Hit Optimization for Potential Use in Cancer Disease |
Hiba Zalloum, Mohammad S. Mubarak, Rabab Tayyem, Tala Abu Rjai, Mohammad Kahlil, and Yasser Al Bustanji |
2012 |
Deanship of Academic Research/ UJ
|
Ongoing |
Synthesis, Characterization and Anti-Cancer Activity of Novel Amidrazone Derivatives |
Hiba Zalloum, Mohammad S. Mubarak and Meqdad Al-Habashneh |
2014 |
Hamdi Mango Center for Scientific Research/ UJ |
Ongoing |
Synthesis, Characterization and Anti-Cancer Activity of Novel Amidrazone Derivatives |
Meqdad Al-Habashneh, Hiba Zalloum and Mohammad S. Mubarak |
2014 |
Deanship of Academic Research/ UJ
|
Ongoing |
Discovery of Novel Potent STAT3 Inhibitors for Potential Treatment of Cancer |
Abla A-Bsoul, Malek Zihlif and Hiba Zalloum |
2014 |
Deanship of Academic Research/ UJ
|
Ongoing |
Discovery of New HER2 Inhibitors via Ligand-Based Pharmacophore Modeling and Hit Optimization for Potential Use in Cancer Disease. |
Hiba Zalloum, Mohammad S. Mubarak, Rabab Tayyem and Malek Zihlif |
2015 |
Abdul Hameed Shoman Foundation |
Ongoing |